Polygenic risk scores: how much do they add?
- 24 April 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 32 (3) , 157-162
Abstract
Purpose of review: Current methods to assess genetic risk of familial hypercholesterolemia and coronary artery disease (CAD) focus on testing monogenic mutations in well known genes. Here we review recent developments in polygenic risk scores (PRSs) for LDL cholesterol and for CAD, and how they may add to current risk prediction algorithms. Recent findings: PRSs can identify 10–20 times as many individuals at high polygenic risk compared with monogenic mutations, and PRSs can modulate the effect of a monogenic variant on risk. Current risk factor prediction tools for prevention of CAD incompletely capture polygenic susceptibility, and PRSs may identify subgroups of patients who are likely to benefit more from lipid-lowering therapy. Finally, PRSs can be quantified already at birth, long before other risk factors used to predict CAD, and before clinical manifestations of disease. Summary: PRSs for CAD may soon be incorporated into clinical practice. Therefore, there is an urgent need to establish both analytical and clinical reporting standards for PRSs, and for validating scores in different ethnicities. Thresholds for intervention need to be established for PRSs and integrated into established risk scores. Training programs are needed for clinical staff to learn to communicate polygenic risk in a comprehensive way to the patient.Keywords
This publication has 32 references indexed in Scilit:
- Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery DiseaseJACC, 2020
- Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart DiseaseJAMA, 2020
- Predictive Accuracy of a Polygenic Risk Score–Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery DiseaseJAMA, 2020
- Genomic Risk Prediction of Coronary Artery Disease in 480,000 AdultsJACC, 2018
- Deep-coverage whole genome sequences and blood lipids among 16,324 individualsNature Communications, 2018
- Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutationsNature Genetics, 2018
- Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention SettingCirculation, 2017
- Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary DiseaseNew England Journal of Medicine, 2016
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaJACC, 2016
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskCirculation, 2014